These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2219309)

  • 1. A model of the corneal allograft reaction.
    Duguid IG; Cuthbertson RA; Guymer RH; Williams KA; Mandel TE
    Transplant Proc; 1990 Oct; 22(5):2105-6. PubMed ID: 2219309
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of corneal allograft rejection after penetrating keratoplasty by antibodies to ICAM-1 and LFA-1 in mice.
    Yamagami S; Obata H; Tsuru T; Isobe M
    Transplant Proc; 1995 Apr; 27(2):1899-900. PubMed ID: 7725542
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of monoclonal antibody on corneal graft survival across major and minor histocompatibility mismatches.
    Duguid IG; Koulmanda M; Mandel TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):844. PubMed ID: 8438499
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of monoclonal antibody to VLA-4 on corneal allograft survival in mice.
    Hori J; Yamagami S; Obata H; Tsuru T; Isobe M
    Transplant Proc; 1996 Jun; 28(3):1990-1. PubMed ID: 8658970
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of cytotoxic T lymphocytes in corneal allograft rejection.
    Hegde S; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3341-7. PubMed ID: 11006223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T-cell-independent rejection of corneal allografts.
    Niederkorn JY; Stevens C; Mellon J; Mayhew E
    Transplantation; 2006 Apr; 81(8):1171-8. PubMed ID: 16641604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of costimulatory pathway modulation on corneal allograft survival.
    Watson MP; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3417-22. PubMed ID: 16877411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
    Yamada J; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced IL-10 and decreased IL-2 production after orthotopic corneal transplantation in mice.
    Hasková Z; Filipec M; Holán V
    Folia Biol (Praha); 1999; 45(1):21-5. PubMed ID: 10732714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
    Matoba AY; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of allergic conjunctival inflammation on the allogeneic response to donor cornea.
    Flynn TH; Ohbayashi M; Ikeda Y; Ono SJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4044-9. PubMed ID: 17724186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that active suppression contributes to the success of H-2-incompatible orthotopic corneal allografts in mice.
    Sonoda Y; Ksander B; Streilein JW
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1374-6. PubMed ID: 8442147
    [No Abstract]   [Full Text] [Related]  

  • 14. Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?
    Hargrave SL; Mayhew E; Hegde S; Niederkorn J
    Transpl Immunol; 2003; 11(1):79-89. PubMed ID: 12727479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of corneal allografts and xenografts to antibody-mediated rejection.
    Holán V; Vítová A; Krulová M; Zajícová A; Neuwirth A; Filipec M; Forrester JV
    Immunol Lett; 2005 Sep; 100(2):211-3. PubMed ID: 15869803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression.
    Beutelspacher SC; Pillai R; Watson MP; Tan PH; Tsang J; McClure MO; George AJ; Larkin DF
    Eur J Immunol; 2006 Mar; 36(3):690-700. PubMed ID: 16482510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of CXCL-1/KC production in high risk vascularized corneal allografts on T cell recruitment and graft rejection.
    Amescua G; Collings F; Sidani A; Bonfield TL; Rodriguez JP; Galor A; Medina C; Yang X; Perez VL
    Transplantation; 2008 Feb; 85(4):615-25. PubMed ID: 18347542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86.
    Kagaya F; Hori J; Kamiya K; Kaji Y; Oshika T; Amano S; Yamagami S; Tsuru T; Tanaka S; Matsuda H; Yagita H; Okumura K
    Exp Eye Res; 2002 Jan; 74(1):131-9. PubMed ID: 11878826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model of allogeneic corneal endothelial cell transplantation.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Cornea; 2008 Jul; 27(6):699-705. PubMed ID: 18580263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.